Treatment of Severe Hyperglycemia with Glucose >500 mg/dL
For severe hyperglycemia with glucose levels over 500 mg/dL, immediate intravenous insulin infusion is the most appropriate treatment, followed by transition to a basal-bolus insulin regimen once stabilized. 1
Initial Management
Immediate Treatment
- Start continuous intravenous regular insulin infusion:
- Adult patients: Initial IV bolus of regular insulin at 0.15 units/kg body weight, followed by continuous infusion at 0.1 unit/kg/hour (typically 5-7 units/hour) 2
- Pediatric patients: No initial bolus; start continuous infusion at 0.1 unit/kg/hour 2
- Monitor glucose every 30 minutes to 2 hours until stable 1
Fluid Replacement
- Initiate aggressive fluid replacement:
Electrolyte Management
- Monitor and replace potassium:
Monitoring During Treatment
- Check blood glucose every 30 minutes to 2 hours during IV insulin therapy 1
- Monitor electrolytes, especially potassium, every 2-4 hours 2
- Assess mental status regularly to identify complications 2
- Target glucose range: 140-180 mg/dL for most patients 2
Transition from IV to Subcutaneous Insulin
- Calculate total daily dose (TDD) based on average insulin infusion rate over previous 12 hours 1
- Administer subcutaneous insulin 1-2 hours before discontinuing IV insulin to prevent rebound hyperglycemia 1
- Convert to basal insulin at 60-80% of the daily infusion dose 1
- Implement basal-bolus regimen (not sliding scale alone) 1
- 50% as basal insulin (long-acting)
- 50% as prandial insulin (rapid-acting) divided between meals 1
Maintenance Regimen
Basal-bolus insulin regimen:
Target glucose range:
Common Pitfalls to Avoid
Relying solely on sliding-scale insulin - This reactive approach treats hyperglycemia after it occurs rather than preventing it 1
Improper transition from IV to subcutaneous insulin - Can lead to rebound hyperglycemia; always overlap subcutaneous and IV insulin by 1-2 hours 1
Inadequate total insulin dose - Failure to adjust both basal and bolus components leads to poor glucose control 1
Too rapid correction of glucose - May lead to cerebral edema, especially in pediatric patients 2
Neglecting potassium monitoring - Insulin therapy can cause hypokalemia 3
Special Considerations
For patients with glucose >500 mg/dL but who are clinically stable with mild symptoms, outpatient management with subcutaneous insulin may be considered 2
For patients with diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), additional specific protocols should be followed 2
Patients with severe hyperglycemia should be evaluated for precipitating factors such as infection, medication non-adherence, or new-onset diabetes 3
Remember that severe hyperglycemia (>500 mg/dL) represents a medical emergency that requires prompt treatment to prevent life-threatening complications. The cornerstone of management is insulin therapy, fluid replacement, and careful monitoring.